Clinical trial
Efficacy of Combined PEV3A Virosomal Vaccine and FP9-MVA ME-TRAP Prime Boost…
NCT00408668 · University of Oxford, Other · Completed
Key facts
| NCT number | NCT00408668 |
|---|---|
| Title | Efficacy of Combined PEV3A Virosomal Vaccine and FP9-MVA ME-TRAP Prime Boost Regimen |
| Official title | Assessment of Protection Against Malaria by Sporozoite Challenge of Healthy Adults Vaccinated With the Virosomal Vaccine PEV3A and FP9-MVA ME-TRAP. A Phase I / IIa Controlled Challenge Trial |
| Lead sponsor | University of Oxford, Other |
| Collaborators | Medical Research Council Pevion Biotech Ltd Industry Swiss Tropical & Public Health Institute Walter Reed Army Institute of Research (WRAIR) U.S. Fed |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Malaria, Falciparum |
| Intervention type | Biological |
| Interventions | PEV3A, FP9 ME-TRAP, MVA ME-TRAP |
| Enrollment | 30 |
| Start date | Aug 1, 2005 |
| Completion | Feb 1, 2006 |
| First posted | Dec 7, 2006 |
| Last update posted | Dec 7, 2006 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: